Ewen Sedman is a seasoned leader in the pharmaceutical industry, having held various senior roles at Merck KGaA and Merck Serono, including Senior Vice President for Research Neurodegenerative Diseases and Global Head of Operational Excellence Research. With a strong focus on clinical development and strategy, Ewen contributed to significant projects, including the FDA approval of vilazodone and the establishment of a new operational function at Merck Serono. Currently, Ewen serves as a Non-Executive Board Member at the EspeRare Foundation, continuing their commitment to advancing research in rare diseases. Ewen earned a Combined Honours degree in Physiology with Pharmacology from the University of Southampton.
This person is not in the org chart
This person is not in any teams
This person is not in any offices